{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Russo A"],"funding":["Region of Campania, Italy"],"pagination":["973"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10459783"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(8)"],"pubmed_abstract":["<h4>Introduction</h4>Acute kidney disease and chronic kidney disease are considered conditions that can increase the mortality and severity of COVID-19. However, few studies have investigated the impact of creatinine levels on COVID-19 progression in patients without a history of chronic kidney disease. The aim of the study was to assess the impact of creatinine levels at hospital admission on COVID-19 progression and mortality.<h4>Methods</h4>We performed a multicenter, observational, retrospective study involving seventeen COVID-19 Units in the Campania region in southern Italy. All adult (≥18 years) patients, hospitalized with a diagnosis of SARS-CoV-2 infection confirmed by a positive reverse transcriptase-polymerase chain reaction on a naso-oropharyngeal swab, from 28 February 2020 to"],"journal":["Pathogens (Basel, Switzerland)"],"pubmed_title":["Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study."],"pmcid":["PMC10459783"],"funding_grant_id":["DGR no. 140 of 17 March 2020; DGR n. 504 of 10.11.2021"],"pubmed_authors":["Monari C","Ponticiello A","Russo G","Maggi P","Masullo A","Esposito V","Allegorico E","Gambardella M","Gentile I","Onorato L","Sangiovanni V","Pisaturo M","Ciminelli F","Dell'Aquila G","Parrella R","Coppola N","Calabria G","Manzillo E","CoviCamp Group","Russo A","Carriero C","Gentile V","Pisapia R"],"additional_accession":[]},"is_claimable":false,"name":"Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study.","description":"<h4>Introduction</h4>Acute kidney disease and chronic kidney disease are considered conditions that can increase the mortality and severity of COVID-19. However, few studies have investigated the impact of creatinine levels on COVID-19 progression in patients without a history of chronic kidney disease. The aim of the study was to assess the impact of creatinine levels at hospital admission on COVID-19 progression and mortality.<h4>Methods</h4>We performed a multicenter, observational, retrospective study involving seventeen COVID-19 Units in the Campania region in southern Italy. All adult (≥18 years) patients, hospitalized with a diagnosis of SARS-CoV-2 infection confirmed by a positive reverse transcriptase-polymerase chain reaction on a naso-oropharyngeal swab, from 28 February 2020 to","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jul","modification":"2025-04-26T20:26:57.829Z","creation":"2024-11-13T13:34:40.334Z"},"accession":"S-EPMC10459783","cross_references":{"pubmed":["37623933"],"doi":["10.3390/pathogens12080973"]}}